Amundi - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
Amundi ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$613,100
+17.0%
10,958
-20.4%
0.00%
Q2 2023$524,224
-54.8%
13,770
-56.0%
0.00%
-100.0%
Q1 2023$1,160,191
+682.1%
31,272
+769.6%
0.00%
Q4 2022$148,335
-52.6%
3,596
-19.2%
0.00%
Q3 2022$313,000
+513.7%
4,451
+424.3%
0.00%
Q2 2022$51,000
-99.4%
849
-98.8%
0.00%
-100.0%
Q4 2021$8,588,000
-36.0%
72,330
-4.6%
0.01%
-44.4%
Q3 2021$13,420,000
-22.3%
75,855
-29.0%
0.01%
-25.0%
Q2 2021$17,267,000106,8960.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,000,000$31,470,0008.67%
Baker Brothers Advisors 2,805,074$88,276,0000.77%
Broadfin Capital, LLC 359,661$11,319,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 397,660$12,514,0000.42%
Boulegeris Investments, Inc. 17,415$548,0000.39%
SPHERA FUNDS MANAGEMENT LTD. 95,000$2,990,0000.29%
Rhenman & Partners Asset Management AB 50,000$1,574,0000.19%
Integre Asset Management, LLC 23,996$755,0000.16%
Orbimed Advisors 680,500$21,415,0000.16%
EAM Investors, LLC 38,754$1,220,0000.14%
View complete list of MIRATI THERAPEUTICS INC shareholders